CSIMarket Company Name, Ticker, Industry, else..
 
Viatris Inc   (NASDAQ: VTRS)
 

Viatris Inc's Suppliers Performance

VTRS's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
VTRS Costs vs Sales of Suppliers Growth Viatris Inc recorded an increase in cost of sales by 2.27 % year on year, relative to one quarter ago cost of sales fell by -2.52 % in Q2.

• More on VTRS Suppliers



Viatris Inc recorded increase in cost of sales by 2.27 % year on year, compare to one quarter ago cost of sales fell by -2.52 % in Q2.

• More on VTRS Suppliers




Viatris Inc's Comment on Supply Chain


The Company is engaged in restructuring activities, including vendor consolidations and product transfer costs, as part of its sourcing, manufacturing, and supply chain optimization efforts. These activities are expected to result in significant charges and generate savings. The Company prioritizes supply chain continuity and is evolving its generics portfolio toward more profitable products. It serves customers globally through a commercial infrastructure spanning over 165 countries and territories. The Company has a history of FDA approvals for generic versions of various drugs and is developing innovative, patent-protected assets alongside first-to-market generics opportunities.

Viatris Inc's Comment on Supply Chain


The Company is engaged in restructuring activities, including vendor consolidations and product transfer costs, as part of its sourcing, manufacturing, and supply chain optimization efforts. These activities are expected to result in significant charges and generate savings. The Company prioritizes supply chain continuity and is evolving its generics portfolio toward more profitable products. It serves customers globally through a commercial infrastructure spanning over 165 countries and territories. The Company has a history of FDA approvals for generic versions of various drugs and is developing innovative, patent-protected assets alongside first-to-market generics opportunities.







VTRS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Viatris Inc 20,264.69 14,737.30 -410.70 30,000
SUBTOTAL 0.00 0.00 0.00 -


Sources: Viatris Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Viatris Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.